Related Experiment Video
Updated: Feb 5, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated
Tao Hu1, Jingyang Zhang1,2, Beibei Sha1
1College of Basic Medical Sciences, Zhengzhou University; Collaborative Innovation Center of Henan province for cancer chemoprevention, Zhengzhou, China.
Abstract:
Increasing evidence suggests that deubiquitinase USP7 participates in tumor progression by various mechanisms and serves as a potential therapeutic target. However, its expression and role in esophageal cancer remains elusive; the anti-cancer effect by targeting USP7 still needs to be investigated. Here, we reported that USP7 was overexpressed in esophageal squamous cell carcinoma (ESCC) tissues compared with adjacent tissues, implying that USP7 was an attractive anticancer target of ESCC. Pharmaceutical or genetic inactivation of USP7 inhibited esophageal cancer cells growth in vitro and in vivo and induced apoptosis. Mechanistically, inhibition of USP7 accumulated poly-ubiquitinated proteins, activated endoplasmic reticulum stress, and increased expression of ATF4, which transcriptionally upregulated expression of NOXA and induced NOXA-mediated apoptosis. These results provide an evidence for clinical investigation of USP7 inhibitors for the treatment of ESCC.
Insights
Deubiquitinase USP7 is overexpressed in esophageal squamous cell carcinoma (ESCC). Targeting USP7 inhibits ESCC growth and induces apoptosis, suggesting its potential as a therapeutic target for ESCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Deubiquitinase USP7 is implicated in various cancers.
- Its role and therapeutic potential in esophageal cancer are largely unknown.
- Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.
Purpose of the Study:
- To investigate the expression and function of USP7 in ESCC.
- To evaluate the anti-cancer effects of targeting USP7 in ESCC.
- To elucidate the underlying molecular mechanisms of USP7 inhibition in ESCC.
Main Methods:
- Quantitative analysis of USP7 expression in ESCC tissues.
- In vitro and in vivo studies using pharmaceutical or genetic USP7 inhibition.
- Analysis of protein ubiquitination, endoplasmic reticulum stress markers, and apoptosis pathways.
Main Results:
- USP7 was significantly overexpressed in ESCC tissues compared to adjacent normal tissues.
- USP7 inhibition suppressed ESCC cell proliferation and induced apoptosis both in vitro and in vivo.
- USP7 inhibition led to accumulation of poly-ubiquitinated proteins, ER stress, and ATF4 upregulation, ultimately activating NOXA-mediated apoptosis.
Conclusions:
- USP7 is a promising therapeutic target for ESCC.
- Targeting USP7 demonstrates significant anti-cancer effects in ESCC models.
- Further clinical investigation of USP7 inhibitors for ESCC treatment is warranted.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Apoptosis
Cells Coordinate Growth and Proliferation
Cell-mediated Immune Responses
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

